Literature DB >> 11893906

Frequent alterations of the beta-catenin protein in cancer of the uterine cervix.

Ana Laura Pereira-Suárez1, Marco Antonio Meraz, Marcela Lizano, Ciro Estrada-Chávez, Fernando Hernández, Primitivo Olivera, Elizabeth Pérez, Patricia Padilla, Moshe Yaniv, Françoise Thierry, Alejandro García-Carrancá.   

Abstract

Cancer of the uterine cervix is still the leading cause of death among women with cancer in developing countries. Although infections with human papillomavirus are necessary, other molecular alterations that are needed at the cellular level for development of these tumors remain largely unknown. Beta-catenin is a key regulator located within the Wnt signaling cascade whose alterations constitute an important event in colon carcinogenesis. In many malignancies increased levels of the beta-catenin protein have been found, associated with its nuclear and/or cytoplasmic accumulation. To search for possible alterations of this pathway we examined the expression and localization of the beta-catenin protein in tumors from the uterine cervix and cell lines derived from them. Beta-catenin was found accumulated in the cytoplasm and/or nuclei of 12 out of 32 samples. In accordance, increased levels of this protein were observed in 9 out of 20 tumors analyzed. Importantly, PCR-SSCP and sequence analysis showed no mutations in exons 3, 4 and 6 of the beta-catenin gene. Our findings indicate that alterations of beta-catenin are frequent in these tumors and suggest that they may play an important role in the development of cancer of the uterine cervix. They also indicate that higher protein levels and abnormal localization may result from several different mechanisms. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893906     DOI: 10.1159/000048688

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

1.  The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo.

Authors:  José Bonilla-Delgado; Gülay Bulut; Xuefeng Liu; Enoc M Cortés-Malagón; Richard Schlegel; Catalina Flores-Maldonado; Rubén G Contreras; Sang-Hyuk Chung; Paul F Lambert; Aykut Uren; Patricio Gariglio
Journal:  Mol Cancer Res       Date:  2011-12-07       Impact factor: 5.852

2.  WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.

Authors:  Amber L Delmas; Bridget M Riggs; Carolina E Pardo; Lisa M Dyer; Russell P Darst; Eugene G Izumchenko; Mänette Monroe; Ardeshir Hakam; Michael P Kladde; Erin M Siegel; Kevin D Brown
Journal:  Carcinogenesis       Date:  2011-08-26       Impact factor: 4.944

3.  Wnt-11 overexpression promoting the invasion of cervical cancer cells.

Authors:  Heng Wei; Ning Wang; Yao Zhang; Shizhuo Wang; Xiaoao Pang; Shulan Zhang
Journal:  Tumour Biol       Date:  2016-03-31

4.  Downregulation of nuclear and cytoplasmic Chibby is associated with advanced cervical cancer.

Authors:  Ming-Chang Yang; Shang-Tao Chien; Tzu-Feng Yang; Shih-Yi Lin; Tai-Min Lee; Yi-Ren Hong
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

5.  High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway.

Authors:  Shichao Zhuang; Xiaohui Yu; Ming Lu; Yujiao Li; Ning Ding; Yumei Ding
Journal:  J Gynecol Oncol       Date:  2020-11       Impact factor: 4.401

Review 6.  Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.

Authors:  Daria A Haręża; Jacek R Wilczyński; Edyta Paradowska
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

7.  AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity.

Authors:  H T Kwan; David W Chan; Patty C H Cai; Celia S L Mak; Mingo M H Yung; Thomas H Y Leung; Oscar G W Wong; Annie N Y Cheung; Hextan Y S Ngan
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

8.  GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.

Authors:  Cuiling Ma; Chenglong Zeng; Liang Jin; Yang Yang; Pengfei Li; Liangfeng Chen; Jian Wang
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

9.  Wnt/β‑catenin pathway activation and silencing of the APC gene in HPV‑positive human cervical cancer‑derived cells.

Authors:  Erick Ayala-Calvillo; Luis Humberto Mojica-Vázquez; Alejandro García-Carrancá; Leticia González-Maya
Journal:  Mol Med Rep       Date:  2017-10-20       Impact factor: 2.952

10.  NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression.

Authors:  Qiqi Wang; Qiong Qin; Ran Song; Chunjuan Zhao; Hua Liu; Ying Yang; Siyu Gu; Deshan Zhou; Junqi He
Journal:  Cell Death Dis       Date:  2018-06-04       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.